Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Economics

Global HPV vaccination provides greatest economic benefit to high income countries

Manufacturers have received economic returns worth five times their original investment in HPV vaccine development, say researchers

The financial benefits of vaccinating all 12-year-old females across the globe found that economic gains per vaccinated female in a high-income country were five times that in a low-income country. In the image, pre-teen is vaccinated

Source: James Gathany / CDC

Vaccinating girls against HPV is now routine in developed countries but not in developing nations 

Cervical cancer kills more than 250,000 women globally each year; 90% of these deaths occur in low or middle income countries, many of which cannot afford the human papillomavirus (HPV) vaccine.

Researchers analysed the economic benefits of vaccinating all 12-year-old females across the globe. They took into account vaccine development, production and distribution costs and compared the economic benefits of improved health and reduced cancer treatment against the costs of purchasing and delivering the vaccine.

The study found that manufacturers have already received an economic return five times their original investment. Economic gains per vaccinated female in a high income country were five times that in a low income country.

Reporting their findings in Health Affairs[1], researchers conclude that subsidising vaccine prices in low and middle income countries could reduce financial barriers and still provide economic benefits for high income countries and profits for vaccine manufacturers.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20200698

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The financial benefits of vaccinating all 12-year-old females across the globe found that economic gains per vaccinated female in a high-income country were five times that in a low-income country. In the image, pre-teen is vaccinated

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.